FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2512324406> ?p ?o ?g. }

• W2512324406 endingPage "150" @default.
• W2512324406 startingPage "144" @default.
• W2512324406 abstract "BackgroundThe purpose of this analysis is to report the change in quality of life (QoL) after treatment with the Argus II Epiretinal Prosthesis in patients with end‐stage retinitis pigmentosa.MethodsThe Vision and Quality of Life Index (VisQoL) was used to assess changes in QoL dimensions and overall utility score in a prospective 30‐patient single‐arm clinical study. VisQoL is a multi‐attribute instrument consisting of six dimensions (injury, life, roles, assistance, activity and friendship) that may be affected by visual impairment. Within each dimension, patients were divided into two groups based on how much their QoL was affected by their blindness at baseline (moderate/severe or minimal). Outcomes were compared within each dimension sub‐group between baseline and the combined follow‐up periods using the Friedman test. In addition, data from the six dimensions were combined into a single utility score, with baseline data compared to the combined follow‐up periods.ResultsOverall, 80 per cent of the patients reported difficulty in one or more dimensions pre‐implant. Composite VisQoL utility scores at follow‐up showed no statistically significant change from baseline; however, in three of the six VisQoL dimensions (injury, life and roles), patients with baseline deficits showed significant and lasting improvement after implantation with Argus II. In two of the three remaining dimensions (assistance and activity), data trended toward an improvement. In the final VisQoL dimension (friendship), none of the patients reported baseline deficits, suggesting that patients had largely adjusted to this attribute.ConclusionPatients whose vision negatively affected them with respect to three VisQoL dimensions (that is, getting injured, coping with the demands of their life and fulfilling their life roles) reported significant improvement in QoL after implantation of the Argus II retinal prosthesis. Furthermore, the benefit did not deteriorate at any point during the 36‐month follow‐up, suggesting a long‐term, durable improvement." @default.
• W2512324406 created "2016-09-16" @default.
• W2512324406 creator A5014695135 @default.
• W2512324406 creator A5022551584 @default.
• W2512324406 creator A5026443811 @default.
• W2512324406 creator A5030410429 @default.
• W2512324406 creator A5032740979 @default.
• W2512324406 creator A5034336674 @default.
• W2512324406 creator A5044910336 @default.
• W2512324406 creator A5052578273 @default.
• W2512324406 creator A5054691770 @default.
• W2512324406 creator A5055872355 @default.
• W2512324406 creator A5058387453 @default.
• W2512324406 creator A5078824716 @default.
• W2512324406 creator A5090165352 @default.
• W2512324406 date "2017-03-01" @default.
• W2512324406 modified "2023-10-17" @default.
• W2512324406 title "Improvements in vision‐related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis" @default.
• W2512324406 cites W1593226431 @default.
• W2512324406 cites W1637616187 @default.
• W2512324406 cites W1912107527 @default.
• W2512324406 cites W1986475192 @default.
• W2512324406 cites W1989074613 @default.
• W2512324406 cites W2008846006 @default.
• W2512324406 cites W2022449896 @default.
• W2512324406 cites W2031059778 @default.
• W2512324406 cites W2044054504 @default.
• W2512324406 cites W2050194259 @default.
• W2512324406 cites W2067162223 @default.
• W2512324406 cites W2085039801 @default.
• W2512324406 cites W2121238900 @default.
• W2512324406 cites W2122066587 @default.
• W2512324406 cites W2150144089 @default.
• W2512324406 cites W2159834561 @default.
• W2512324406 cites W2162665620 @default.
• W2512324406 cites W2163328478 @default.
• W2512324406 cites W2255805712 @default.
• W2512324406 cites W2281483877 @default.
• W2512324406 cites W2342090359 @default.
• W2512324406 cites W4250968058 @default.
• W2512324406 doi "https://doi.org/10.1111/cxo.12444" @default.
• W2512324406 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5347867" @default.
• W2512324406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27558213" @default.
• W2512324406 hasPublicationYear "2017" @default.
• W2512324406 type Work @default.
• W2512324406 sameAs 2512324406 @default.
• W2512324406 citedByCount "46" @default.
• W2512324406 countsByYear W25123244062017 @default.
• W2512324406 countsByYear W25123244062018 @default.
• W2512324406 countsByYear W25123244062019 @default.
• W2512324406 countsByYear W25123244062020 @default.
• W2512324406 countsByYear W25123244062021 @default.
• W2512324406 countsByYear W25123244062022 @default.
• W2512324406 countsByYear W25123244062023 @default.
• W2512324406 crossrefType "journal-article" @default.
• W2512324406 hasAuthorship W2512324406A5014695135 @default.
• W2512324406 hasAuthorship W2512324406A5022551584 @default.
• W2512324406 hasAuthorship W2512324406A5026443811 @default.
• W2512324406 hasAuthorship W2512324406A5030410429 @default.
• W2512324406 hasAuthorship W2512324406A5032740979 @default.
• W2512324406 hasAuthorship W2512324406A5034336674 @default.
• W2512324406 hasAuthorship W2512324406A5044910336 @default.
• W2512324406 hasAuthorship W2512324406A5052578273 @default.
• W2512324406 hasAuthorship W2512324406A5054691770 @default.
• W2512324406 hasAuthorship W2512324406A5055872355 @default.
• W2512324406 hasAuthorship W2512324406A5058387453 @default.
• W2512324406 hasAuthorship W2512324406A5078824716 @default.
• W2512324406 hasAuthorship W2512324406A5090165352 @default.
• W2512324406 hasBestOaLocation W25123244061 @default.
• W2512324406 hasConcept C111368507 @default.
• W2512324406 hasConcept C118487528 @default.
• W2512324406 hasConcept C12725497 @default.
• W2512324406 hasConcept C127313418 @default.
• W2512324406 hasConcept C159110408 @default.
• W2512324406 hasConcept C199360897 @default.
• W2512324406 hasConcept C2776760603 @default.
• W2512324406 hasConcept C2779951463 @default.
• W2512324406 hasConcept C2780827179 @default.
• W2512324406 hasConcept C2781114197 @default.
• W2512324406 hasConcept C41008148 @default.
• W2512324406 hasConcept C71924100 @default.
• W2512324406 hasConceptScore W2512324406C111368507 @default.
• W2512324406 hasConceptScore W2512324406C118487528 @default.
• W2512324406 hasConceptScore W2512324406C12725497 @default.
• W2512324406 hasConceptScore W2512324406C127313418 @default.
• W2512324406 hasConceptScore W2512324406C159110408 @default.
• W2512324406 hasConceptScore W2512324406C199360897 @default.
• W2512324406 hasConceptScore W2512324406C2776760603 @default.
• W2512324406 hasConceptScore W2512324406C2779951463 @default.
• W2512324406 hasConceptScore W2512324406C2780827179 @default.
• W2512324406 hasConceptScore W2512324406C2781114197 @default.
• W2512324406 hasConceptScore W2512324406C41008148 @default.
• W2512324406 hasConceptScore W2512324406C71924100 @default.
• W2512324406 hasFunder F4320332161 @default.
• W2512324406 hasIssue "2" @default.
• W2512324406 hasLocation W25123244061 @default.
• W2512324406 hasLocation W25123244062 @default.
• W2512324406 hasLocation W25123244063 @default.

• next